These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2247023)

  • 41. The phospholipid composition of erythrocyte ghosts and plasma lipoproteins in diabetes type 1 in children.
    Watała C; Jóźwiak Z
    Clin Chim Acta; 1990 May; 188(3):211-9. PubMed ID: 2387073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythrocyte lipids in alcohol dependence.
    Jain S; Shetty T; Ray R; Janakiramaiah N
    Indian J Med Res; 1988 Dec; 88():530-5. PubMed ID: 3243615
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus.
    Tong P; Thomas T; Berrish T; Humphriss D; Barriocanal L; Stewart M; Walker M; Wilkinson R; Alberti KG
    Lancet; 1995 Feb; 345(8946):357-8. PubMed ID: 7845118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis.
    Perfetto F; Tarquini R; Tapparini L; Tarquini B
    J Diabetes Complications; 1998; 12(4):187-92. PubMed ID: 9647335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphonuclear leukocyte membrane fluidity, at baseline and after in vitro activation, in obesity with or without diabetes mellitus.
    Lo Presti R; Sinagra D; Montana M; Scarpitta AM; Catania A; Caimi G
    Acta Diabetol; 2002 Apr; 39(1):29-33. PubMed ID: 12043936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies.
    Candiloros H; Muller S; Zeghari N; Donner M; Drouin P; Ziegler O
    Diabetes Care; 1995 Apr; 18(4):549-51. PubMed ID: 7497868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes mellitus: mean erythrocyte aggregation, glycometabolic pattern, red cell Ca2+ content, and erythrocyte membrane dynamic properties.
    Caimi G; Lo Presti R; Montana M; Serra A; Grifò G; Canino B; Catania A; Sarno A
    Microvasc Res; 1993 Nov; 46(3):401-5. PubMed ID: 8121323
    [No Abstract]   [Full Text] [Related]  

  • 48. Dielectric breakdown of the erythrocyte membrane enhances transbilayer mobility of phospholipids.
    Dressler V; Schwister K; Haest CW; Deuticke B
    Biochim Biophys Acta; 1983 Jul; 732(1):304-7. PubMed ID: 6871195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic and electrokinetic behavior of erythrocyte membrane in diabetes mellitus and diabetic cardiovascular disease.
    Adak S; Chowdhury S; Bhattacharyya M
    Biochim Biophys Acta; 2008 Feb; 1780(2):108-15. PubMed ID: 18035063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Red cell membrane protein lateral mobility in diabetes mellitus.
    Caimi G; Serra A; Lo Presti R; Sarno A
    Horm Metab Res; 1992 Sep; 24(9):409-11. PubMed ID: 1427610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proceedings: ATP-dependent reversible masking of erythrocyte membrane phospholipids.
    Gazitt Y; Ohad I; Loyter A
    Isr J Med Sci; 1975 Nov; 11(11):1186. PubMed ID: 1205764
    [No Abstract]   [Full Text] [Related]  

  • 52. Sodium fluorescein influence on the hemorheological profile of non-insulin dependent diabetes mellitus patients.
    Sargento L; Zabala L; Saldanha C; Souza-Ramalho P; Martins-Silva J
    Clin Hemorheol Microcirc; 1999; 20(2):77-84. PubMed ID: 10416808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma and erythrocyte magnesium levels are correlated with oxygen uptake in patients with non-insulin dependent diabetes mellitus.
    Kobayashi T
    Endocr J; 1998 Apr; 45(2):277-83. PubMed ID: 9700483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Red blood cell membrane cholesterol in type 2 diabetes mellitus.
    Nunes JM; Pretorius E
    Thromb Res; 2019 Jun; 178():91-98. PubMed ID: 31003038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases.
    Gillett MP; Besterman EM
    Atherosclerosis; 1975; 22(1):111-24. PubMed ID: 1156468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do cell membrane dynamics participate in insulin resistance?
    Devynck MA
    Lancet; 1995 Feb; 345(8946):336-7. PubMed ID: 7845111
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes induced by hashish constituents on human erythrocyte phospholipids.
    Kalofoutis A; Koutselinis A
    Pharmacol Biochem Behav; 1979 Oct; 11(4):383-5. PubMed ID: 523495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A decision support system for type 1 diabetes mellitus diagnostics based on dual channel analysis of red blood cell membrane fluidity.
    Cordelli E; Maulucci G; De Spirito M; Rizzi A; Pitocco D; Soda P
    Comput Methods Programs Biomed; 2018 Aug; 162():263-271. PubMed ID: 29903493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma phosphatidylethanolamine--a better indicator in the predictability of atherosclerotic complications?
    Kunz F; Stummvoll W
    Atherosclerosis; 1971; 13(3):413-25. PubMed ID: 5119241
    [No Abstract]   [Full Text] [Related]  

  • 60. Red cell membrane protein lateral mobility in vascular atherosclerotic disease: preliminary report.
    Caimi G; Serra A; Lo Presti R; Montana M; Catania A; Sarno A
    Microvasc Res; 1993 May; 45(3):314-7. PubMed ID: 8321145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.